首页> 美国卫生研究院文献>International Journal of Nanomedicine >The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
【2h】

The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility

机译:难溶性ABT-102的无定形固体分散体在水性介质中形成纳米/微粒结构:对溶解度的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 μg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility (“true” supersaturation).
机译:非晶态固体分散体(ASD)是用于难溶性活性药物成分(API)的有前途的配制方法,因为它们理想地提高了溶出度和溶解度。但是,其背后的机制尚未得到详细了解。在本研究中,我们研究了超分子和纳米/微粒结构,这些结构在将ASD分散在水性介质中时自发出现,并阐明了它们对溶解度的影响。通过热熔挤出制备的ASD包含难溶性ABT-102(在缓冲液中的溶解度为0.05μg/ mL),亲水性聚合物和三种表面活性剂。与结晶的ABT-102相比,来自ASD配方的ABT-102的表观溶解度提高了200倍。同时,通过逆平衡渗析评估的分子溶解度提高了两倍。非对称流场流分馏与多角度光散射检测器,紫外线检测器和折光仪相结合,使我们能够分离和鉴定无API ASD(安慰剂)和成分的二元/三元混合物。因此,可以将摩尔质量在20,000和90,000之间的超分子组装体分配给聚乙烯吡咯烷酮/乙酸乙烯酯64,而将另外两种组装体分配给不同的表面活性剂组装体(胶束)。分馏后剩余与每个组件相关的ABT-102量通过高效液相色谱法(紫外可见)离线定量。聚合物级分和胶束级分大大提高了ABT-102的表观溶解度。此外,通过离心分离微粒级分,并通过扫描电子显微镜,X射线散射和红外光谱法进行分析。发现该微粒是无定形的,并且除了ABT-102作为主要成分外还包含两种表面活性剂。假定无定形微粒是观察到的分子溶解度增加(“真正”过饱和)的起源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号